FDA website in the section of News & Events for Human Drugs
While its function is the same as the other drugs, its slightly different from Ozempic and Wegovy
Quick answer: People may gain weight after stopping Ozempic or Mounjaro because appetite, cravings, and blood sugar changes can return once the medication wears off
District Court in Trenton, claim that Novo Nordisk failed to adequately warn doctors and patients about the risk of developing Non-Arteritic Anterior Ischemic Optic Neuropathy, also called NAION, a serious and irreversible condition that leads to sudden blindness. SI live June 18, 2025- Already facing thousands of Ozempic lawsuits and Wegovy lawsuits over gastrointestinal problems that have been brought in the federal court system, Novo Nordisk now also faces a growing number of claims involving vision loss, which some plaintiffs are requesting be consolidated into a mass tort in New Jersey state court. About lawsuits June 18, 2025- June 6, 2025- European Medicines Agency report May 20, 2025- More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications such as Ozempic have caused a loss of vision
The FDA says state-licensed compounding pharmacies must immediately stop making most compound versions of GLP-1 drugs based on tirzepatide
